Login / Signup
How can artificial intelligence be utilized for de novo drug design against COVID-19 (SARS-CoV-2)?
Giuseppe Floresta
Chiara Zagni
Vincenzo Patamia
Antonio Rescifina
Published in:
Expert opinion on drug discovery (2023)
Keyphrases
</>
artificial intelligence
sars cov
machine learning
big data
deep learning
respiratory syndrome coronavirus
coronavirus disease
adverse drug
drug induced
emergency department